Aged garlic extract preserves beta-cell functioning via modulation of nuclear factor kappa-B /Ca2+ in diabetes mellitus

• Published in: Diabetology and metabolic syndrome 2024-05, Vol.16 (1)
• Main Authors: Ali, Sofi Imtiyaz, Elkhalifa, Ahmed M. E, Nabi, Showkat Ul, Hayyat, Faisal Sualeh, Nazar, Mehak, Taifa, Syed, Rakhshan, Rabia, Shah, Iqra Hussain, Shaheen, Muzaffer, Wani, Imtiyaz Ahmad, Muzaffer, Umar, Shah, Ovais Shabir, Makhdoomi, Dil Mohammad, Ahmed, Elsadig Mohamed, Khalil, Khalil A. A, Bazie, Elsharif.A, Zawbaee, Khalid Ibrahim, Al Hasan Ali, Moataz Mohamed, Alanazi, Rakan J, Al Bataj, Ibrahim Ali, Al Gahtani, Saeed Musfar, Salwi, Ali Jubran, Alrodan, Lina Saeed
• Format: Article
• Language: English
• Subjects: Adenosine triphosphatase; Analysis; Antioxidants; Blood sugar; Ethylenediaminetetraacetic acid; Glucose tolerance tests; Health aspects; Infrared spectroscopy; Insulin; Insulin resistance; Mass spectrometry; Pancreatic beta cells; Streptozocin; Tryptophan; Type 2 diabetes
• ISSN: 1758-5996; 1758-5996
• DOI: 10.1186/s13098-024-01350-8

Background Peripheral insulin resistance and compromised insulin secretion from pancreatic [beta]-cells are significant factors and pathogenic hallmarks of diabetes mellitus (DM). NF-κ[beta]/TLR-4 and SERCA/Ca.sup.2+ pathways have been identified as potential pathways regulating insulin synthesis by preserving pancreatic [beta]-cell functioning. The current study aimed to evaluate the therapeutic effect of aged garlic extract (AGE) against DM in a streptozotocin (STZ)-induced rat model with particular emphasis on pancreatic [beta]-cell functioning. Methods AGE was characterized by gas chromatography-mass spectrometry (GC-MS), Fourier-transform infrared spectroscopy (FTIR), and scanning electron microscopy (SEM) to evaluate its physio-chemical characteristics followed by in-vitro anti-diabetic and antioxidant potential. This was followed by the induction of DM in laboratory animals for investigating the therapeutic action of AGE by evaluating the role of NF-κ[beta]/TLR-4 and the SERCA/Ca.sup.2+ pathway. The parameters assessed in the present experimental setup encompassed antioxidant parameters, metabolic indicators, insulin concentration, intracellular calcium levels, apoptotic markers (CCK-8 and Caspase Glo-8), and protein expression (P-62 and APACHE-II). Results AGE characterization by SEM, GC-MS, and X-ray diffraction (XRD) revealed the presence of phenylalanine, alliin, S-allylmercaptocysteine (SAMC), tryptophan, 1-methyl-1,2,3,4-tetrahydro-[beta]-carboline-3-carboxylic acid as major bioactive constituents of AGE. Metabolic studies, including intraperitoneal glucose tolerance test (IPGTT), revealed significantly lower blood glucose levels in the AGE group compared to the disease control group. In contrast, the intraperitoneal insulin tolerance test (ITT) exhibited no significant difference in insulin sensitivity between the AGE supplementation group and the DM control group. Interestingly, AGE was found to have no significant effect on fasting glucose and serum insulin levels. In contrast, AGE supplementation was found to cause significant hypoglycaemia in postprandial blood glucose and insulin levels. Importantly, AGE causes restoration of intracellular Ca.sup.2+ levels by modulation of SERCA/Ca.sup.2 functioning and inhibition NF-κB/TLR-4 pathway. AGE was found to interact with and inhibit the DR-5/ caspase-8/3 apoptotic complex. Furthermore, microscopic studies revealed degeneration and apoptotic changes in pancreatic [beta]-cells of the DM contr